close

Synovis Life Technologies, Inc., a medical device company, engages in the development, manufacture, marketing, and sale of products for the surgical treatment of diseases. Its products include implantable biomaterial products and devices for microsurgery and surgical tools, which are used to reduce risk and/or facilitate critical surgeries. The company's biomaterial products include Peri-Strips that are biomaterial stapling buttress used as reinforcement at the surgical staple line; Tissue-Guard, which is used to repair and replace damaged tissue in cardiac, vascular, thoracic, and neurologic procedures; and Veritas Collagen Matrix for use in surgery to repair and replace soft tissue. Its devices for microsurgery comprise Microvascular Anastomotic Coupler, which enables microsurgeons in various surgical specialties to perform anastomotic microsurgical procedures; and Neurotube, a device designed to assist in the reconnection of severed nerves. Synovis Life Technologies sells its products through direct sales force and independent distributors primarily in the United States, Europe, Canada, and the Asia Pacific region. The company, formerly known as Bio-Vascular, Inc., was founded in 1985 and is headquartered in St. Paul, Minnesota.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	28.01
Volume	0
Volume Avg	162882
52 Week High	28.01
52 Week Low	13.21
PE	38.37
PE (group average)	39
EPS Year	0.73
EPS change Q/Q	6.25%
EPS change Q/Q Yr ago	54.55%
EPS change Q/Q next Q est	-10.53%
EPS change Y/Y	-86.44%
REV change Q/Q	1.54%
REV change Q/Q Yr ago	12.5%
EPS next Q est	0.19
EPS next Y est	1.04
Divident Annual	0.00
Dividend Yield	0%